1. Home
  2. UNCY vs PSQH Comparison

UNCY vs PSQH Comparison

Compare UNCY & PSQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • PSQH
  • Stock Information
  • Founded
  • UNCY 2016
  • PSQH 2021
  • Country
  • UNCY United States
  • PSQH United States
  • Employees
  • UNCY N/A
  • PSQH N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • PSQH Advertising
  • Sector
  • UNCY Health Care
  • PSQH Consumer Discretionary
  • Exchange
  • UNCY Nasdaq
  • PSQH Nasdaq
  • Market Cap
  • UNCY 74.2M
  • PSQH 76.2M
  • IPO Year
  • UNCY 2021
  • PSQH N/A
  • Fundamental
  • Price
  • UNCY $4.36
  • PSQH $1.61
  • Analyst Decision
  • UNCY Strong Buy
  • PSQH Strong Buy
  • Analyst Count
  • UNCY 4
  • PSQH 2
  • Target Price
  • UNCY $63.75
  • PSQH $6.00
  • AVG Volume (30 Days)
  • UNCY 483.3K
  • PSQH 1.2M
  • Earning Date
  • UNCY 08-14-2025
  • PSQH 08-12-2025
  • Dividend Yield
  • UNCY N/A
  • PSQH N/A
  • EPS Growth
  • UNCY N/A
  • PSQH N/A
  • EPS
  • UNCY N/A
  • PSQH N/A
  • Revenue
  • UNCY N/A
  • PSQH $27,580,806.00
  • Revenue This Year
  • UNCY N/A
  • PSQH $67.78
  • Revenue Next Year
  • UNCY $3,131.28
  • PSQH $78.76
  • P/E Ratio
  • UNCY N/A
  • PSQH N/A
  • Revenue Growth
  • UNCY N/A
  • PSQH 93.83
  • 52 Week Low
  • UNCY $3.24
  • PSQH $1.55
  • 52 Week High
  • UNCY $11.00
  • PSQH $7.77
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 49.39
  • PSQH 40.11
  • Support Level
  • UNCY $4.15
  • PSQH $1.58
  • Resistance Level
  • UNCY $4.35
  • PSQH $1.76
  • Average True Range (ATR)
  • UNCY 0.24
  • PSQH 0.16
  • MACD
  • UNCY 0.05
  • PSQH 0.00
  • Stochastic Oscillator
  • UNCY 53.76
  • PSQH 6.45

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

Share on Social Networks: